- Home
- ENVB vs GCTK Comparison
ENVB vs GCTK Comparison
Compare ENVB & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- GCTK
- Stock Information
- Founded
- ENVB 1994
- GCTK 2001
- Country
- ENVB United States
- GCTK United States
- Employees
- ENVB N/A
- GCTK N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- ENVB Health Care
- GCTK Health Care
- Exchange
- ENVB Nasdaq
- GCTK Nasdaq
- Market Cap
- ENVB 3.0M
- GCTK 3.3M
- IPO Year
- ENVB N/A
- GCTK N/A
- Fundamental
- Price
- ENVB $0.97
- GCTK $10.59
- Analyst Decision
- ENVB Strong Buy
- GCTK
- Analyst Count
- ENVB 1
- GCTK 0
- Target Price
- ENVB $10.00
- GCTK N/A
- AVG Volume (30 Days)
- ENVB 325.7K
- GCTK 4.0M
- Earning Date
- ENVB 08-14-2025
- GCTK 08-14-2025
- Dividend Yield
- ENVB N/A
- GCTK N/A
- EPS Growth
- ENVB N/A
- GCTK N/A
- EPS
- ENVB N/A
- GCTK N/A
- Revenue
- ENVB N/A
- GCTK N/A
- Revenue This Year
- ENVB N/A
- GCTK N/A
- Revenue Next Year
- ENVB N/A
- GCTK N/A
- P/E Ratio
- ENVB N/A
- GCTK N/A
- Revenue Growth
- ENVB N/A
- GCTK N/A
- 52 Week Low
- ENVB $0.85
- GCTK $4.22
- 52 Week High
- ENVB $8.33
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- ENVB 40.51
- GCTK 79.88
- Support Level
- ENVB $0.85
- GCTK $4.33
- Resistance Level
- ENVB $1.06
- GCTK $5.88
- Average True Range (ATR)
- ENVB 0.10
- GCTK 0.88
- MACD
- ENVB -0.02
- GCTK 0.42
- Stochastic Oscillator
- ENVB 19.34
- GCTK 64.21
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.